https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-rss/?orgId=114792&title=Latest+News A selection of the latest research, academic, and other newsworthy developments at Yale Fibrosis Program en-us Copyright 2026 Yale School of Medicine Fri, 15 May 2026 04:24:09 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/searching-for-a-cure-for-pulmonary-fibrosis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/searching-for-a-cure-for-pulmonary-fibrosis/ In the lab of Erica Herzog, MD, PhD, scientists are working to cure pulmonary fibrosis, researching the condition's underlying mechanisms to inform approaches for prevention and treatment. Tue, 31 Mar 2026 12:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/inaugural-connecticut-liver-health-day-aims-to-increase-awareness-of-liver-disease/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/inaugural-connecticut-liver-health-day-aims-to-increase-awareness-of-liver-disease/ Connecticut recently designated liver disease as a public health priority and established April 19 as an annual Connecticut Liver Health Day to promote awareness, prevention, and earlier detection of liver disease statewide. On April 19, 2026, Yale School of Medicine will co-host the Connecticut Liver Health Day Educational Luncheon with the Liver and Health Innovation Consortium. Mon, 30 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/fellow-focus-in-four-michail-kokkorakis-md-phd/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/fellow-focus-in-four-michail-kokkorakis-md-phd/ Meet postdoctoral fellow, Michail Kokkorakis, MD, PhD, whose work focuses on improving the detection and treatment of liver disease. Kokkorakis was recently selected as a Young Scientist for the 75th Lindau Nobel Laureate Meeting. Thu, 26 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/breathe-better-longer-new-clues-to-shortness-of-breath-in-older-adults/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/breathe-better-longer-new-clues-to-shortness-of-breath-in-older-adults/ A new Yale School of Medicine study points to progressive stiffening of the pulmonary artery, the main vessel supplying blood to the lungs, as a potential explanation for some of the age-related declines in heart and lung function. Mon, 09 Mar 2026 13:21:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/how-lungs-age-and-targets-for-preventing-disease/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/how-lungs-age-and-targets-for-preventing-disease/ Scientists created a cellular atlas of the lungs to pinpoint cells especially vulnerable to aging. They could be targets for preventing acute and chronic lung diseases. Tue, 03 Mar 2026 16:00:00 Z https://yalealumnimagazine.org/articles/6174 https://yalealumnimagazine.org/articles/6174 Can mimicking nature unravel the mysteries of the immune system? Meet Anjelica Gonzalez, a bioengineer forging new paths, one cell wall at a time. Sun, 01 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/zooming-in-on-copd-a-single-cell-view-of-the-diseased-lung/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/zooming-in-on-copd-a-single-cell-view-of-the-diseased-lung/ People diagnosed with chronic obstructive pulmonary disease often experience markedly different symptoms, disease trajectories, and responses to treatment. To better understand this variability, a new study from researchers at Yale School of Medicine used single-cell sequencing technology alongside complementary spatial transcriptomic and proteomic analyses to examine lung tissue from people with COPD in unprecedented detail. Thu, 29 Jan 2026 15:27:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/drug-induced-pneumonitis-the-risk-behind-new-cancer-therapies/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/drug-induced-pneumonitis-the-risk-behind-new-cancer-therapies/ A new review aims to help clinicians better recognize subtle signs of pneumonitis before they escalate. Tue, 20 Jan 2026 18:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/the-future-of-medicine-physician-scientists-and-mentorship/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/the-future-of-medicine-physician-scientists-and-mentorship/ For Erica Herzog, MD, PhD, being a mentor is a privilege that is immensely fulfilling. This summer, two of Herzog’s mentees met career benchmarks, and both credit Herzog and her guidance for getting them there. Mon, 15 Dec 2025 21:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/kaminski-to-step-down-as-yale-pccsm-section-chief/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/kaminski-to-step-down-as-yale-pccsm-section-chief/ When Naftali Kaminski, MD, was recruited to Yale in 2013 as section chief of Pulmonary, Critical Care and Sleep Medicine (Yale-PCCSM) he planned to lead it for 10 years. Now, coming up on his thirteenth year, he is stepping down at the end of June 2026. Mon, 27 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/yale-pccsm-faculty-earn-national-recognition-at-chest/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/yale-pccsm-faculty-earn-national-recognition-at-chest/ Each year, the American College of Chest Physicians (CHEST) honors the clinicians, researchers, and educators shaping the future of chest medicine. Among this year’s distinguished honorees are several faculty members from the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine (Yale-PCCSM), recognized for their leadership, innovation, and dedication to the field. Wed, 01 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/advancing-therapies-for-pulmonary-fibrosis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/advancing-therapies-for-pulmonary-fibrosis/ Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure. Mon, 25 Aug 2025 04:00:00 Z https://www.health.com/bmi-body-fat-percentage-more-reliaboe-study-11770445 https://www.health.com/bmi-body-fat-percentage-more-reliaboe-study-11770445 Recent research found that BMI is not a good predictor of mortality, adding to a growing body of evidence against the health metric. Here's what to measure instead. Tue, 15 Jul 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/yale-internal-medicine-faculty-recognized-for-pioneering-diagnostic-innovation/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/yale-internal-medicine-faculty-recognized-for-pioneering-diagnostic-innovation/ When it comes to medical diagnosis, timing and accuracy can mean the difference between recovery and irreversible harm. For two Yale Department of Internal Medicine faculty members — Snigdha Jain, MD, MHS, and Bubu Banini, MD, PhD — getting the diagnosis right, and getting it early, is an important clinical goal. Wed, 09 Jul 2025 17:18:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/apply-now-yale-liver-center-pilot-funding-2025/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/apply-now-yale-liver-center-pilot-funding-2025/ The NIH/NIDDK P30 Liver Center grant provides for the annual submission of pilot projects ($40,000 direct costs each) from both Liver Center and non-Liver Center investigators. Tue, 01 Jul 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/ai-helps-researchers-understand-lung-disease-and-proposes-treatment/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/ai-helps-researchers-understand-lung-disease-and-proposes-treatment/ Yale researchers developed an AI model that illuminates critical details about—and possible treatments for—idiopathic pulmonary fibrosis. It could do so for many other diseases. Fri, 20 Jun 2025 09:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/ryu-to-receive-ats-rising-star-award/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/ryu-to-receive-ats-rising-star-award/ Wonnie Ryu, MD, MPH, is the recipient of the American Thoracic Society (ATS) Assembly on Respiratory Cell and Molecular Biology Rising Star Award. Fri, 09 May 2025 13:20:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/phage-therapy-may-treat-drug-resistance-in-patients-with-cystic-fibrosis-study-finds/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/phage-therapy-may-treat-drug-resistance-in-patients-with-cystic-fibrosis-study-finds/ In a new study, published in Nature Medicine, a team of researchers at the Center for Phage Biology and Therapy at Yale discovered a novel approach that may revolutionize the fight against antimicrobial resistance. Mon, 05 May 2025 12:30:00 Z https://news.yale.edu/2025/04/09/bridge-builders-awards-celebrate-those-who-strengthen-bond-between-yale-and-new-haven https://news.yale.edu/2025/04/09/bridge-builders-awards-celebrate-those-who-strengthen-bond-between-yale-and-new-haven Nine individuals and organizations from across Yale and New Haven were recognized during the annual Seton Elm-Ivy Awards ceremony on April 8. Wed, 09 Apr 2025 16:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/connecticut-academy-of-science-and-engineering-elects-12-from-ysm/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/connecticut-academy-of-science-and-engineering-elects-12-from-ysm/ Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering. Tue, 18 Mar 2025 22:00:00 Z https://ventures.yale.edu/news/blavatnik-fund-innovation-yale-support-15-breakthrough-interventions-cardiometabolic https://ventures.yale.edu/news/blavatnik-fund-innovation-yale-support-15-breakthrough-interventions-cardiometabolic This year’s awardees are tackling some of the most urgent life science challenges with projects spanning novel therapeutics to AI-powered medical solutions. Fri, 28 Feb 2025 05:00:00 Z https://news.yale.edu/2025/02/05/study-reveals-how-gut-bacteria-might-trigger-autoimmune-diseases-lupus https://news.yale.edu/2025/02/05/study-reveals-how-gut-bacteria-might-trigger-autoimmune-diseases-lupus Gut bacteria are increasingly implicated in non-gut-related autoimmune diseases. Yale researchers have begun to understand how they’re connected. Fri, 07 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/responding-to-rise-of-metabolic-liver-disease-in-connecticut/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/responding-to-rise-of-metabolic-liver-disease-in-connecticut/ Metabolic liver diseases are on the rise in Connecticut. Yale faculty joined a new state working group to respond to the increase in the prevalence of these diseases. The working group recently issued recommendations to increase awareness and education and improve public health infrastructure. Mon, 27 Jan 2025 05:00:00 Z https://www.today.com/health/behavior/drinking-alcohol-doctors-recommendations-rcna188526 https://www.today.com/health/behavior/drinking-alcohol-doctors-recommendations-rcna188526 And some may be under the impression that a glass of wine with dinner is actually healthy, Dr. Bubu Banini, assistant professor of medicine in digestive diseases at the Yale School of Medicine, tells TODAY.com. Mon, 27 Jan 2025 05:00:00 Z https://www.theflowspace.com/physical-health/prevention-longevity/alcohol-cancer-risk-women-health-dry-january-2960293/ https://www.theflowspace.com/physical-health/prevention-longevity/alcohol-cancer-risk-women-health-dry-january-2960293/ Learn about the link between alcohol and cancer risk for women, including breast cancer & heart disease. Explore expert insights and prevention tips. Sun, 26 Jan 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/digestive-health-cme-series-2025/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/digestive-health-cme-series-2025/ The Trust Your Gut continuing medical education (CME) series is returning for 2025 to provide physicians and advanced practice providers with world-class, evidence-based digestive disease education. Each webinar will be delivered by experts across the Yale School of Medicine. Mon, 06 Jan 2025 05:00:00 Z https://ventures.yale.edu/news/yale-life-science-pitchfest-2024-showcases-groundbreaking-research-and-innovation https://ventures.yale.edu/news/yale-life-science-pitchfest-2024-showcases-groundbreaking-research-and-innovation From novel therapeutic treatments for obesity and endometriosis to a simulated psychedelic immersive experience to treat depression and a unisex non-hormonal contraceptive, the 2024 Yale Life Science PitchFest showcased Yale's most promising life science innovations from 34 Yale faculty-led teams. Thu, 12 Dec 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/babesiosis-biology-pathogenicity-research-yale/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/babesiosis-biology-pathogenicity-research-yale/ Babesiosis, a tick-borne disease caused by Babesia parasites, is on the rise in the United States. The disease often presents with flu-like symptoms, but in some individuals, can progress to a more severe condition. Yet, despite the increasing significance of babesiosis in public health, there is limited understanding of the parasites’ biology, pathogenesis, and mechanism of virulence. Building on research initially reported in 2018 by a team of scientists led by Choukri Ben Mamoun, PhD, professor of medicine (infectious diseases), of microbial pathogenesis, and of pathology at Yale School of Medicine, the National Institutes of Health (NIH) awarded a $834,372 grant to further investigate Babesia biology and pathogenicity. Thu, 24 Oct 2024 04:00:00 Z https://www.everydayhealth.com/cancer/drinking-alcohol-increases-the-risk-of-six-types-of-cancer/ https://www.everydayhealth.com/cancer/drinking-alcohol-increases-the-risk-of-six-types-of-cancer/ Excessive alcohol use is linked to over 200 different diseases, says Bubu Banini, MD, PhD, a member of the Yale Cancer Center and the associate director of the Clinical and Translational Core at the Yale Liver Center in New Haven, Connecticut. Thu, 26 Sep 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/yale-conference-for-alcohol-research-and-education-2024-call-for-abstracts/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/yale-conference-for-alcohol-research-and-education-2024-call-for-abstracts/ The Yale Conference for Alcohol Research and Education (YCARE) 2024 will take place on Saturday, October 19, 2024. The event is a dynamic day of learning, interaction, and collaboration focused on the theme of alcohol research. This year’s in-person event will feature podium talks, breakout sessions, a panel discussion, poster presentations, and more avenues to learn from and network with colleagues. Mon, 23 Sep 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/gut-microbiome-imbalance-promotes-liver-disease-in-cystic-fibrosis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/gut-microbiome-imbalance-promotes-liver-disease-in-cystic-fibrosis/ About 30% of patients with cystic fibrosis report liver abnormalities and 10% of these patients go on to experience severe liver disease. Traditionally, cystic fibrosis-related liver disease was thought to be caused primarily by defective bile secretion due to the dysfunctional CFTR protein, which limited treatment options. Yale’s recent study led by Romina Fiorotto, PhD, and Mario Strazzabosco, MD, PhD, has identified a connection between the gut microbiome and the development of liver disease in cystic fibrosis patients. Tue, 27 Aug 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/immune-profile-identified-fibrotic-hypersensitivity-pneumonitis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/immune-profile-identified-fibrotic-hypersensitivity-pneumonitis/ Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale’s Section of Pulmonary, Critical Care and Sleep Medicine have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature. Their findings were recently published in the American Journal of Respiratory and Critical Care Medicine. Wed, 21 Aug 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/making-antifungal-medications-more-effective/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/making-antifungal-medications-more-effective/ A new study led by Yale researchers uncovers a new cellular process that links the metabolism of vitamin B5 to the ability of fungi to detoxify drugs. These findings represent a significant leap in our understanding of fungal resistance mechanisms and herald new treatment possibilities for combating resilient fungal strains, with far-reaching implications for patients worldwide. Wed, 31 Jul 2024 04:00:00 Z https://ventures.yale.edu/news/11-yale-projects-receive-awards-colton-center-autoimmunity https://ventures.yale.edu/news/11-yale-projects-receive-awards-colton-center-autoimmunity The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases. In addition to grant funding, Colton Center awardees receive mentorship, access to industry expertise, and feedback on their potential commercialization. Thu, 11 Jul 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/carolyn-rochester-received-ats-pulmonary-rehabilitation-lifetime-achievement-award/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/carolyn-rochester-received-ats-pulmonary-rehabilitation-lifetime-achievement-award/ The American Thoracic Society (ATS) presented Carolyn Rochester, MD, FCCP, with the Assembly on Pulmonary Rehabilitation Lifetime Achievement Award at the ATS International Conference in late May 2024 in San Diego. Mon, 01 Jul 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/applications-for-yale-liver-center-pilot-funding2024/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/applications-for-yale-liver-center-pilot-funding2024/ The NIH/NIDDK P30 Liver Center grant provides for the annual submission of pilot projects ($40,000 direct costs each) from both Liver Center and non-Liver Center investigators. Tue, 18 Jun 2024 04:00:00 Z https://www.buzzfeed.com/anikanayak/signs-liver-damage https://www.buzzfeed.com/anikanayak/signs-liver-damage Bubu Banini, MD, PhD, assistant professor of medicine (digestive diseases) at Yale School of Medicine, discusses signs and symptoms of liver disease. Sun, 09 Jun 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/single-cell-profiling-reveals-insights-about-immunity-in-idiopathic-pulmonary-fibrosis/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/single-cell-profiling-reveals-insights-about-immunity-in-idiopathic-pulmonary-fibrosis/ In a new study, published in the American Journal of Respiratory and Critical Care Medicine, researchers used single-cell RNA sequencing to measure the gene expressions of individual peripheral blood mononuclear cells in patients with progressive IPF, patients with stable IPF, and lung-disease-free patients. Previously, the researchers had studied bulk samples of these cells but not examined them individually and in detail. Thu, 30 May 2024 12:58:00 Z https://www.medscape.com/viewarticle/how-treat-alcohol-use-disorder-patients-liver-disease-2024a10009i2 https://www.medscape.com/viewarticle/how-treat-alcohol-use-disorder-patients-liver-disease-2024a10009i2 For gastroenterologists treating alcohol-associated liver disease (ALD), gaining an understanding of a patient's alcohol consumption is crucial for distinguishing it from other conditions and tailoring subsequent interventions. Mon, 20 May 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/dr-naftali-kaminski-behind-the-scenes-new-medical-podcast/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/dr-naftali-kaminski-behind-the-scenes-new-medical-podcast/ Naftali Kaminski, MD, Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine and chief of Pulmonary, Critical Care, and Sleep Medicine (Yale-PCCSM), recently partnered with the American Thoracic Society (ATS) to launch a new podcast. Thu, 09 May 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/search-affordable-treatment-option-liver-disease/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/search-affordable-treatment-option-liver-disease/ Until very recently, no treatment options were available for metabolic-associated steatolic liver disease (MASLD) (previously called non-alcoholic fatty liver disease). The Food and Drug Administration recently approved resmetirom, the first therapy for the more severe form of MASLD, but there remains a need for a generic, affordable treatment option for patients. Bubu Banini, MD, PhD, was recently awarded a $3.05 million R01 grant by the National Institutes of Health (NIH) for a five-year research project to investigate the feasibility of oral digoxin as a treatment option for these patients. Thu, 09 May 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/lisa-korn-receives-2024-dostanic-award/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/lisa-korn-receives-2024-dostanic-award/ Lisa Korn, MD, PhD, instructor of medicine (rheumatology, allergy and immunology) has been selected to receive the 2024 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award. Wed, 10 Apr 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/translational-research-in-idiopathic-pulmonary-fibrosis-wonnie-ryu-yale/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/translational-research-in-idiopathic-pulmonary-fibrosis-wonnie-ryu-yale/ In a Q&A, Changwan "Wonnie" Ryu, MD, MPH, who recently won the ASCI Council Young Physician-Scientist Award, discusses the role of innate immunity in the development of idiopathic pulmonary fibrosis, his goal as a physician-scientist, and the inspiration behind his work. Thu, 15 Feb 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/mehran-sadeghi-receives-senior-clinician-scientist-investigator-award/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/mehran-sadeghi-receives-senior-clinician-scientist-investigator-award/ Mehran M. Sadeghi, MD, professor of medicine (cardiovascular medicine), recently received the prestigious Senior Clinician Scientist Investigator Award from the United States Department of Veterans Affairs (VA). The award recognizes clinician-scientists who have demonstrated exceptional dedication to research and clinical care for veterans. Fri, 09 Feb 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/dr-carolyn-rochester-journey-pulmonary-rehabilitation/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/dr-carolyn-rochester-journey-pulmonary-rehabilitation/ In October 2023, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) honored Carolyn Rochester, MD, FCCP, professor of medicine, with the prestigious Thomas L. Petty Distinguished Pulmonary Scholar Award. The award is presented to an individual “who has made significant advances in the field of pulmonary rehabilitation through research and scholarly contributions and has earned national prominence in the field.” Thu, 04 Jan 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/new-yale-program-addresses-rare-lung-infection/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/new-yale-program-addresses-rare-lung-infection/ The new Yale Bronchiectasis and NTM Infections Program at the Winchester Center for Lung Disease specializes in treating patients with chronic respiratory tract infections, including one caused by nontuberculous mycobacteria. Tue, 28 Nov 2023 14:57:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/winchester-center-for-lung-disease-flourishing/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/winchester-center-for-lung-disease-flourishing/ The Winchester Center for Lung Disease (WCLD) opened in March 2021 at the North Haven Medical Center to improve access to exceptional care for more people with lung conditions. The expanded facilities at the Winchester Center have allowed expansion of subspecialized pulmonary care as well as access to a wide array of multidisciplinary services, more than what was possible at the original Winchester Chest Clinic (WCC) on Yale New Haven Hospital’s York Street Campus. Mon, 27 Nov 2023 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/kyle-bramley-interventional-pulmonary-yale/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/kyle-bramley-interventional-pulmonary-yale/ The Yale Interventional Pulmonary team in Yale’s Section of Pulmonary, Critical Care, and Sleep Medicine (Yale-PCCSM) employs advanced technologies to diagnose and treat diseases in the chest, such as lung nodules and masses, lymph node enlargement, complex airways, and pleural effusions. The program, led by Kyle Bramley, MD, assistant professor of medicine (pulmonary), was one of the first interventional pulmonology programs in Connecticut when it was established in 2009. Today it remains the largest interventional pulmonary service in the state. Mon, 20 Nov 2023 05:00:00 Z https://medicine.yale.edu/ysm/news/yale-medicine-magazine/article/the-next-era-of-obesity/ https://medicine.yale.edu/ysm/news/yale-medicine-magazine/article/the-next-era-of-obesity/ The next era of obesity medicine Wed, 01 Nov 2023 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/assessing-symptoms-in-older-adults-after-icu/ https://websites4-live-prod.ysmdevs.com/internal-medicine/fibrosis/news-article/assessing-symptoms-in-older-adults-after-icu/ Older adults who survive a critical illness, such as sepsis or respiratory failure, often have symptoms that restrict activities, but little is known about how these symptoms change over time or compare with those prior to illness, and whether these changes differ among vulnerable subgroups. In a new study, Yale researchers evaluated changes in restricting symptoms among adults aged 70 or older during the six months after discharge from the ICU or intensive care unit. Wed, 25 Oct 2023 12:50:00 Z